Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Life Saving Move! India Rejects Abbott’s HIV drug patent
Abbott’s HIV Drug Patent Plea Rejected for Lack of Novelty
Abbott’s Patent Plea for HIV Drug Rejected
Patent Office Rejects Abbot’s Application on HIV Drug
India Rejects Abbott Lab’s Patent Application for HIV Drug
Abbott Patent Application for HIV Spurned
India Rejects HIV Drug Application By Abbott Laboratories
India Rejects Patent Application by Abbott for Lifesaving HIV Drug
India Rejects Sham Patent Application for Lifesaving HIV Drug: Pharmaceuticals in India now free to help HIV patients worldwide
Priti Radhakrishnan Speaks About the Future of Trade and Access to Medcinines at the Spotlight on the Millennials